RSLS (ReShape Lifesciences) Price Chart

ReShape Lifesciences (RSLS) is recognized as a developer of gentle methods for combating metabolic disorders and excess weight, earning acclaim from physicians. However, the rapid success of new GLP-1 weight-loss drugs is undermining its competitive advantages and eroding profits. This chart of the share price, which currently stands at 15.66, complements data regarding synergy with clinics during the implementation of Lap-Band systems.

Price Chart: reshapelifesciences.com (RSLS) for 07/04/2022 - 08/30/2025

Comprehensive metric breakdowns and analytics for ReShape Lifesciences Inc (RSLS)

- stock value and consensus price forecast:

Price Chart ReShape Lifesciences|RSLS - Fair Value Consensus

- business market valuation indicators:

Market Value ReShape Lifesciences, Inc.|RSLS - Company Buyout Price

- balance sheet equity data:

Net Assets per Single Share ReShape Lifesciences|RSLS - Company Book Value|Market Value to Book Value Ratio reshapelifesciences.com|RSLS - Company Total Asset Base

- debt and liquidity details:

- company profitability and valuation multiples indicators:

RSLS - Net Profit|Expected Profit ReShape Lifesciences|RSLS - Market Cap to Net Income|Forward P/E Multiple ReShape Lifesciences|RSLS - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio ReShape Lifesciences, Inc.|RSLS - Operating profit EBITDA|Net earnings per share for the last 12 months ReShape Lifesciences|RSLS - Earnings per share for the last four quarters|Quarterly EPS earnings growth reshapelifesciences.com|RSLS - Expected net earnings per share growth this year|Earnings growth forecast for next year ReShape Lifesciences

Fundamental valuation:ReShape Lifesciences Inc.

Product sample of ReShape Lifesciences Inc

The price reflects the market consensus regarding asset value and future cash flows, reacting instantaneously to any changes in the issuer's fundamental indicators. By analyzing the price action chronology, an investor can see how ReShape Lifesciences (RSLS) is impacting capitalization and shaping a long-term business development trend through cost optimization via the outsourcing of weight loss system assembly.

Competitors of ReShape Lifesciences (RSLS)